Weiss Ratings Reiterates Sell (E+) Rating for 111 (NASDAQ:YI)

111 (NASDAQ:YIGet Free Report)‘s stock had its “sell (e+)” rating reissued by stock analysts at Weiss Ratings in a note issued to investors on Saturday,Weiss Ratings reports.

111 Price Performance

NASDAQ:YI traded down $0.00 during trading hours on Friday, reaching $0.43. 436,991 shares of the stock were exchanged, compared to its average volume of 265,025. 111 has a twelve month low of $0.41 and a twelve month high of $1.60. The stock has a market cap of $36.39 million, a PE ratio of -1.06 and a beta of 0.43. The firm has a 50 day moving average of $0.68 and a 200 day moving average of $0.82.

Shares of 111 are going to reverse split on the morning of Friday, January 24th. The 1-10 reverse split was announced on Wednesday, January 8th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, January 23rd.

About 111

(Get Free Report)

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.

See Also

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.